Abstract
Netherlands Wound Care Management Investment Opportunities, Analysis and
Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating
to Netherlands wound care management market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the wound care management in
Netherlands
Scope
・ The report provides wound care management information broken down into
detailed categories and segments in Netherlands.
・ Total revenues,
products sold, end users, and average pricing.
・ Market shares of all the
key competitors.
・ Key pipeline products that are set to shape the
market, broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the wound care management market in
Netherlands.
・ Evaluate and compare the attractiveness of the market in
the country.
・ Identify growth segments and opportunities in each
industry sector within the country.
・ Evaluate the pipeline of key
products that will change the sector, and identify threats and opportunities
before the products are launched in the country.
・ Analyze the
competitiveness of the market in the country and identify hotspots.
・
Develop strategies based on the latest product, brand, expansion and research
and development news in the country.
・ Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have
shaped the market in the country.
・ Identify and analyze the strengths and
weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What Is This Report About? 15
2.2 Definitions
15
2.2.1 Wound Care Management 15
3 Healthcare Sector Review 17
3.1 Healthcare Expenditure 17
3.2 Healthcare Infrastructure 20
3.3
Healthcare Policy 22
3.3.1 Health Insurance Act 23
3.3.2 Healthcare
Allowance Act 23
3.3.3 The Exceptional Medical Expenses Act 23
4 Wound
Care Management in Netherlands 24
4.1 Wound Care Management Overall
Revenues (2000-2012) 24
4.2 Wound Care Management Overall Volume
(2000-2012) 30
4.3 Wound Care Management Overall Company Shares
(2005-2006) 33
5 Wound Closure Devices in Netherlands 34
5.1 Wound
Closure Devices Overall Revenues (2000-2012) 34
5.1.1 Skin Closure Devices
Overall Revenues (2000-2012) 38
5.1.2 Hemostats Overall Revenues
(2000-2012) 40
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 42
5.2 Wound Closure Devices Overall Volume (2000-2012) 44
5.2.1 Skin Closure
Devices Overall Volume (2000-2012) 46
5.2.2 Tissue Sealants Overall Volume
(2000-2012) 48
5.2.3 Hemostats Overall Volume (2000-2012) 50
5.3 Wound
Closure Devices Average Price (2000-2012) 52
5.3.1 Hemostats Average Price
(2000-2012) 52
5.3.2 Tissue Sealants Average Price (2000-2012) 54
5.3.3 Skin Closure Devices Average Price (2000-2012) 56
5.4 Wound Closure
Devices Distribution Share (2000-2012) 58
5.5 Wound Closure Devices
Company Share (2000-2012) 59
6 Ostomy in Netherlands 60
6.1 Ostomy
Overall Revenue (2000-2012) 60
6.2 Ostomy Overall Volume (2000-2012)
62
6.3 Ostomy Average Price (2000-2012) 64
6.4 Ostomy Distribution
Share (2005-2006) 66
6.5 Ostomy Company Share (2005-2006) 67
7
Advanced Wound Management in Netherlands 68
7.1 Advanced Wound Management
Overall Revenue (2000-2012) 68
7.2 Advanced Wound Management Overall
Volume (2000-2012) 70
7.3 Advanced Wound Management Average Price
(2000-2012) 72
7.4 Advanced Wound Management Distribution Share
(2005-2006) 74
7.5 Advanced Wound Management Company Share (2005-2006)
75
8 Traditional Wound Management in Netherlands 76
8.1 Traditional
Wound Management Overall Revenue (2000-2012) 76
8.2 Traditional Wound
Management Overall Volume (2000-2012) 78
8.3 Traditional Wound Management
Average Price (2000-2012) 80
8.4 Traditional Wound Management Distribution
Share (2000-2012) 82
8.5 Traditional Wound Management Company Share
(2000-2012) 83
9 Compression Therapy in Netherlands 84
9.1 Compression
Therapy Overall Revenue (2000-2012) 84
9.2 Compression Therapy Category
Volume (2000-2012) 86
9.3 Compression Therapy Average Price (2000-2012)
88
9.4 Compression Therapy Distribution Share (2000-2012) 90
9.5
Compression Therapy Company Share (2000-2012) 91
10 Baxter International
Company Profile 92
10.1 Company Overview 92
10.2 Business Overview
92
10.2.1 BioScience 92
10.2.2 Medication Delivery 92
10.2.3 Renal
93
10.2.4 Products 93
10.2.5 History 94
10.3 Value Chain Analysis
97
10.3.1 Manufacturing 97
10.3.2 Product Development 97
10.3.3
Sales and Marketing 98
10.4 SWOT Analysis 99
10.4.1 Baxter
International Inc. Strengths 99
10.4.2 Baxter International Inc.
Weaknesses 100
10.4.3 Baxter International Inc. Opportunities 100
10.4.4 Baxter International Inc. Threats 101
10.5 Financial and
Operational Review 102
10.6 Locations And Subsidiaries 103
10.7 Baxter
International Inc. Pipeline Products 105
10.7.1 Next-Generation Home
Hemodialysis Machine 105
11 Smith & Nephew Plc Company Profile 107
11.1 Company Overview 107
11.2 Business Overview 107
11.2.1 Advanced
Wound Management 107
11.2.2 Endoscopy 107
11.2.3 Reconstruction
108
11.2.4 Trauma and Clinical Therapies 109
11.2.5 Products 109
11.2.6 History 110
11.3 Value Chain Analysis 113
11.3.1 Manufacturing
114
11.3.2 Product Development 114
11.3.3 Sales and Marketing 115
11.4 SWOT Analysis 115
11.4.1 Smith & Nephew Plc Strengths 116
11.4.2
Smith & Nephew Plc Weaknesses 116
11.4.3 Smith & Nephew Plc Opportunities
117
11.4.4 Smith & Nephew Plc Threats 117
11.5 Financial and
Operational Review 119
11.6 Locations And Subsidiaries 120
11.7 Smith
& Nephew Plc Pipeline Products 122
11.7.1 R3 Modular resurfacing
Acetabular system 122
11.7.2 R3 Ceramic-on-ceramic Acetabular System
122
12 The HARTMANN GROUP Company Profile 123
12.1 Company Overview
123
12.2 Business Overview 123
12.2.1 Incontinence Management 123
12.2.2 Operating Theater Management 123
12.2.3 Other GROUP Activities
124
12.2.4 Wound Management 124
12.2.5 Products 124
12.2.6 History
125
12.3 Value Chain Analysis 127
12.3.1 Manufacturing 127
12.3.2
Product Development 127
12.3.3 Sales and Marketing 128
12.4 SWOT
Analysis 128
12.4.1 HARTMANN GROUP Strengths 128
12.4.2 HARTMANN GROUP
Weaknesses 129
12.4.3 HARTMANN GROUP Opportunities 129
12.4.4 HARTMANN
GROUP Threats 130
12.5 Financial and Operational Review 131
12.6
Locations And Subsidiaries 132
13 Coloplast A/S Company Profile 134
13.1 Company Overview 134
13.2 Business Overview 134
13.2.1 Medical
Care 134
13.2.2 Major Products and Services 135
13.2.3 History 135
13.3 Value Chain Analysis 137
13.3.1 Manufacturing 137
13.3.2 Product
Development 137
13.3.3 Sales and Marketing 138
13.4 SWOT Analysis
139
13.4.1 Coloplast A/S Strengths 139
13.4.2 Coloplast A/S Weaknesses
140
13.4.3 Coloplast A/S Opportunities 141
13.4.4 Coloplast A/S
Threats 141
13.5 Financial and Operational Review 142
13.5.1 Financial
Statements 142
13.5.2 Financial Ratios 143
13.5.3 Share Holding
Structure 143
13.6 Locations And Subsidiaries 144
14 ConvaTec Company
Profile 146
14.1 Company Overview 146
14.2 Business Overview 146
14.2.1 Major Products and Services 146
14.2.2 History 147
14.3
Locations And Subsidiaries 148
15 Regulation System 149
15.1 Medical
Equipment Approval Process 149
15.1.1 Classification of Medical Devices
149
15.1.2 Conformity Assessment Process 159
15.2 Post Market
Surveillance (PMS) 162
16 Pricing and Reimbursement 163
16.1 Pricing
and Reimbursement in Netherlands 163
17 Distribution Structure 164
17.1 Distribution Structure in Netherlands 164
18 Financial Deals
Landscape 165
18.1 Acquisition 165
18.1.1 aap Implantate Acquires Fame
Holding 165
19 Appendix 167
19.1 Global Markets Direct Research
Methodology 167
19.2 Coverage 168
19.3 Secondary Research 168
19.4
Primary Research 169
19.5 Models 169
19.6 Forecasts 170
19.7
Expert Panels 170
19.8 Currency Conversion 171
19.9 Contact Us 172
19.10 Disclaimer 172
1.1 List of Tables
Table 1: Doctors by
Specialty in Netherlands, 2000-2006 21
Table 2: Hospital Wards by Type in
Netherlands, 2000-2006 22
Table 3: Wound Care Management, Netherlands,
Overall Revenues ($ mn), 2000-2012 24
Table 4: Wound Care Management,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 25
Table 5:
Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 26
Table 6: Wound Care Management, Netherlands, Category
Revenues ($ mn), 2000-2012 27
Table 7: Wound Care Management, Netherlands,
Category Revenues ($ mn), Historic, 2000-2007 28
Table 8: Wound Care
Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012 29
Table 9: Wound Care Management, Netherlands, Category Volume (Units),
2000-2012 30
Table 10: Wound Care Management, Netherlands, Category Volume
(Units), Historic, 2000-2007 31
Table 11: Wound Care Management,
Netherlands, Category Volume (Units), Forecast, 2007-2012 32
Table 12:
Wound Care Management, Netherlands, Overall Company Share by Revenue ($ mn),
2005-2006 33
Table 13: Wound Closure Devices, Netherlands, Overall
Revenues ($ mn), Historic, 2000-2007 34
Table 14: Wound Closure Devices,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 35
Table 15:
Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic,
2000-2007 36
Table 16: Wound Closure Devices, Netherlands, Revenue by
Segment ($ mn), Forecast, 2007-2012 37
Table 17: Skin Closure Devices,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 38
Table 18:
Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 39
Table 19: Hemostats, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 40
Table 20: Hemostats, Netherlands, Overall Revenues
($ mn), Forecast, 2007-2012 41
Table 21: Tissue Sealants, Netherlands,
Overall Revenues ($ mn), Historic, 2000-2007 42
Table 22: Tissue Sealants,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 43
Table 23:
Wound Closure Devices, Netherlands, Overall Volume (Units), Historic,
2000-2007 44
Table 24: Wound Closure Devices, Netherlands, Overall Volume
(Units), Forecast, 2007-2012 45
Table 25: Skin Closure Devices,
Netherlands, Overall Volume (Units), Historic, 2000-2007 46
Table 26: Skin
Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
47
Table 27: Tissue Sealants, Netherlands, Overall Volume (Units),
Historic, 2000-2007 48
Table 28: Tissue Sealants, Netherlands, Overall
Volume (Units), Forecast, 2007-2012 49
Table 29: Hemostats, Netherlands,
Overall Volume (Units), Historic, 2000-2007 50
Table 30: Hemostats,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 51
Table 31:
Hemostats, Netherlands, Average Price ($), Historic, 2000-2007 52
Table
32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012 53
Table 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007
54
Table 34: Tissue Sealants, Netherlands, Average Price ($), Forecast,
2007-2012 55
Table 35: Skin Closure Devices, Netherlands, Average Price
($), Historic, 2000-2007 56
Table 36: Skin Closure Devices, Netherlands,
Average Price ($), Forecast, 2007-2012 57
Table 37: Wound Closure Devices,
Netherlands, Distribution Share by Revenue ($ mn), 2005-2006 58
Table 38:
Wound Closure Devices, Netherlands, Company Share by Revenue ($ mn), 2005-2006
59
Table 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 60
Table 40: Ostomy, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 61
Table 41: Ostomy, Netherlands, Overall Volume
(Units), Historic, 2000-2007 62
Table 42: Ostomy, Netherlands, Overall
Volume (Units), Forecast, 2007-2012 63
Table 43: Ostomy, Netherlands,
Average Price ($), Historic, 2000-2007 64
Table 44: Ostomy, Netherlands,
Average Price ($), Forecast, 2007-2012 65
Table 45: Ostomy, Netherlands,
Distribution Share by Revenue ($ mn), 2005-2006 66
Table 46: Ostomy,
Netherlands, Company Share by Revenue ($ mn), 2005-2006 67
Table 47:
Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 68
Table 48: Advanced Wound Management, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 69
Table 49: Advanced Wound
Management, Netherlands, Overall Volume (Units), Historic, 2000-2007 70
Table 50: Advanced Wound Management, Netherlands, Overall Volume (Units),
Forecast, 2007-2012 71
Table 51: Advanced Wound Management, Netherlands,
Average Price ($), Historic, 2000-2007 72
Table 52: Advanced Wound
Management, Netherlands, Average Price ($), Forecast, 2007-2012 73
Table
53: Advanced Wound Management, Netherlands, Distribution Share by Revenue ($
mn), 2005-2006 74
Table 54: Advanced Wound Management, Netherlands,
Company Share by Revenue ($ mn), 2005-2006 75
Table 55: Traditional Wound
Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 76
Table 56: Traditional Wound Management, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 77
Table 57: Traditional Wound Management,
Netherlands, Overall Volume (Units), Historic, 2000-2007 78
Table 58:
Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast,
2007-2012 79
Table 59: Traditional Wound Management, Netherlands, Average
Price ($), Historic, 2000-2007 80
Table 60: Traditional Wound Management,
Netherlands, Average Price ($), Forecast, 2007-2012 81
Table 61:
Traditional Wound Management, Netherlands, Distribution Share by Revenue ($
mn), 2005-2006 82
Table 62: Traditional Wound Management, Netherlands,
Company Share by Revenue ($ mn), 2005-2006 83
Table 63: Compression
Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 84
Table 64: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 85
Table 65: Compression Therapy, Netherlands, Overall Volume
(Units), Historic, 2000-2007 86
Table 66: Compression Therapy,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 87
Table 67:
Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007
88
Table 68: Compression Therapy, Netherlands, Average Price ($),
Forecast, 2007-2012 89
Table 69: Compression Therapy, Netherlands,
Distribution Share by Revenue ($ mn), 2005-2006 90
Table 70: Compression
Therapy, Netherlands, Company Share by Revenue ($ mn), 2005-2006 91
Table
71: Baxter International Inc., SWOT Analysis, 2006 99
Table 72:
Baxter International Inc., Financial Statements, USD Million, 2002-2006
102
Table 73: Baxter International Inc., Financial Ratios, USD
Million, 2002-2006 103
Table 74: Baxter International Inc., Other
Locations 104
Table 75: Baxter International Inc., Subsidiaries
105
Table 76: Smith & Nephew Plc, SWOT Analysis, 2006 116
Table
77: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
119
Table 78: Smith & Nephew Plc, Financial Ratios, USD Million,
2002-2006 120
Table 79: Smith & Nephew Plc, Other Locations 121
Table 80: HARTMANN GROUP, SWOT Analysis, 2006 128
Table 81:
HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006 131
Table
82: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006 132
Table 83: HARTMANN GROUP, Subsidiaries 133
Table 84: Coloplast
A/S, SWOT Analysis, 2007 139
Table 85: Coloplast A/S, Financial
Statements, DKK Million, 2003-2007 142
Table 86: Coloplast A/S,
Financial Ratios, DKK Million, 2003-2007 143
Table 87: Coloplast A/S,
Share Holding Structure 143
Table 88: Coloplast A/S, Other Locations
144
Table 89: Coloplast A/S, Subsidiaries 145
Table 90:
ConvaTec, Other Locations 148
Table 91: Currency Conversion from USD to
Local Currency at 2007 Constant Rate 171
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006 18
Figure 2: Healthcare Financing Framework in Netherlands, 2005 19
Figure 3:
Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012 24
Figure 4: Wound Care Management, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 25
Figure 5: Wound Care Management, Netherlands,
Overall Revenues ($ mn), Forecast, 2007-2012 26
Figure 6: Wound Care
Management, Netherlands, Category Revenues ($ mn), 2000-2012 27
Figure 7:
Wound Care Management, Netherlands, Category Revenues ($ mn), Historic,
2000-2007 28
Figure 8: Wound Care Management, Netherlands, Category
Revenues ($ mn), Forecast, 2007-2012 29
Figure 9: Wound Care Management,
Netherlands, Category Volume (Units), 2000-2012 30
Figure 10: Wound Care
Management, Netherlands, Category Volume (Units), Historic, 2000-2007 31
Figure 11: Wound Care Management, Netherlands, Category Volume (Units),
Forecast, 2007-2012 32
Figure 12: Wound Care Management, Netherlands,
Overall Company Share (%), 2006 33
Figure 13: Wound Closure Devices,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 34
Figure 14:
Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 35
Figure 15: Wound Closure Devices, Netherlands, Revenue by
Segment ($ mn), Historic, 2000-2007 36
Figure 16: Wound Closure Devices,
Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012 37
Figure 17:
Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 38
Figure 18: Skin Closure Devices, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 39
Figure 19: Hemostats, Netherlands,
Overall Revenues ($ mn), Historic, 2000-2007 40
Figure 20: Hemostats,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 41
Figure 21:
Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
42
Figure 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 43
Figure 23: Wound Closure Devices, Netherlands,
Overall Volume (Units), Historic, 2000-2007 44
Figure 24: Wound Closure
Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012 45
Figure 25: Skin Closure Devices, Netherlands, Overall Volume (Units),
Historic, 2000-2007 46
Figure 26: Skin Closure Devices, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 47
Figure 27: Tissue Sealants,
Netherlands, Overall Volume (Units), Historic, 2000-2007 48
Figure 28:
Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012
49
Figure 29: Hemostats, Netherlands, Overall Volume (Units), Historic,
2000-2007 50
Figure 30: Hemostats, Netherlands, Overall Volume (Units),
Forecast, 2007-2012 51
Figure 31: Hemostats, Netherlands, Average Price
($), Historic, 2000-2007 52
Figure 32: Hemostats, Netherlands, Average
Price ($), Forecast, 2007-2012 53
Figure 33: Tissue Sealants, Netherlands,
Average Price ($), Historic, 2000-2007 54
Figure 34: Tissue Sealants,
Netherlands, Average Price ($), Forecast, 2007-2012 55
Figure 35: Skin
Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007 56
Figure 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast,
2007-2012 57
Figure 37: Wound Closure Devices, Netherlands, Distribution
Share (%), 2006 58
Figure 38: Wound Closure Devices, Netherlands, Company
Share (%), 2006 59
Figure 39: Ostomy, Netherlands, Overall Revenues ($
mn), Historic, 2000-2007 60
Figure 40: Ostomy, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 61
Figure 41: Ostomy, Netherlands,
Overall Volume (Units), Historic, 2000-2007 62
Figure 42: Ostomy,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 63
Figure 43:
Ostomy, Netherlands, Average Price ($), Historic, 2000-2007 64
Figure 44:
Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012 65
Figure 45:
Ostomy, Netherlands, Company Share (%), 2006 67
Figure 46: Advanced Wound
Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 68
Figure 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 69
Figure 48: Advanced Wound Management, Netherlands,
Overall Volume (Units), Historic, 2000-2007 70
Figure 49: Advanced Wound
Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012 71
Figure 50: Advanced Wound Management, Netherlands, Average Price ($),
Historic, 2000-2007 72
Figure 51: Advanced Wound Management, Netherlands,
Average Price ($), Forecast, 2007-2012 73
Figure 52: Advanced Wound
Management, Netherlands, Distribution Share (%), 2006 74
Figure 53:
Advanced Wound Management, Netherlands, Company Share (%), 2006 75
Figure
54: Traditional Wound Management, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 76
Figure 55: Traditional Wound Management,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 77
Figure 56:
Traditional Wound Management, Netherlands, Overall Volume (Units), Historic,
2000-2007 78
Figure 57: Traditional Wound Management, Netherlands, Overall
Volume (Units), Forecast, 2007-2012 79
Figure 58: Traditional Wound
Management, Netherlands, Average Price ($), Historic, 2000-2007 80
Figure
59: Traditional Wound Management, Netherlands, Average Price ($), Forecast,
2007-2012 81
Figure 60: Traditional Wound Management, Netherlands,
Distribution Share (%), 2006 82
Figure 61: Traditional Wound Management,
Netherlands, Company Share (%), 2006 83
Figure 62: Compression Therapy,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 84
Figure 63:
Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
85
Figure 64: Compression Therapy, Netherlands, Overall Volume (Units),
Historic, 2000-2007 86
Figure 65: Compression Therapy, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 87
Figure 66: Compression
Therapy, Netherlands, Average Price ($), Historic, 2000-2007 88
Figure 67:
Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012
89
Figure 68: Compression Therapy, Netherlands, Distribution Share (%),
2006 90
Figure 69: Compression Therapy, Netherlands, Company Share (%),
2006 91
Figure 70: Baxter International Inc., Value Chain Analysis
97
Figure 71: Smith & Nephew Plc, Value Chain Analysis 113
Figure
72: HARTMANN GROUP, Value Chain Analysis 127
Figure 73:
Coloplast A/S, Value Chain Analysis 137
Figure 74: Flowchart for
Classification of Non-invasive Devices in Netherlands, 2007 151
Figure 75:
Flowchart for Classification of Invasive Devices in Netherlands, 2007 152
Figure 76: Flowchart for Classification of Invasive Devices in Netherlands,
2007 153
Figure 77: Flowchart for Classification of Invasive Devices in
Netherlands, 2007 154
Figure 78: Flowchart for Classification of Invasive
Devices in Netherlands, 2007 155
Figure 79: Flowchart for Classification
of Active Devices in Netherlands, 2007 156
Figure 80: Flowchart for
Classification of Active Devices in Netherlands, 2007 157
Figure 81:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in Netherlands, 2007 158
Figure 82: Conformity Assessment
of Class-I Medical Devices in Netherlands, 2007 159
Figure 83: Conformity
Assessment of Class-IIa Medical Devices in Netherlands, 2007 160
Figure
84: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007
161
Figure 85: Conformity Assessment of Class-III Medical Devices in
Netherlands, 2007 162
Figure 86: Global Markets Direct Methodology 167
|
有關報告
|
